Tema ETFs’s Janux Therapeutics JANX Stock Holding History

Tema ETFs’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$951K	Buy	55,053 +3,531	+7%	+$59.3K	0.04%	296
2026 Q2	$791K	Buy	51,522 +333	+0.7%	+$4.82K	0.03%	335
2026 Q1	$712K	Buy	51,189 +14,097	+38%	+$193K	0.05%	297
2025 Q4	$512K	Sell	37,092 -3,259	-8%	-$76.6K	0.04%	352
2025 Q3	$986K	Sell	40,351 -9,714	-19%	-$237K	0.08%	261
2025 Q2	$1.16M	Buy	50,065 +4,128	+9%	+$109K	0.31%	96
2025 Q1	$1.24M	Buy	45,937 +40,714	+780%	+$1.53M	0.37%	80
2024 Q4	$280K	Buy	+5,223	New	+$276K	0.12%	132

Other funds holding JANX

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

West Tower Group Richmond, Virginia $27M AUM 33.41% 1-Year Est. Return

FNY Investment Advisers New York $402M AUM 85.34% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Mather Group Chicago, Illinois $11.8B AUM 12.84% 1-Year Est. Return

Tema ETFs's JANX Position: Q3 2026 in Review

Tema ETFs increased its Janux Therapeutics (JANX) stake by 6.9% in Q3 2026, buying an estimated $59.3K and bringing the position to 55,053 shares worth $951K. The position accounts for 0.04% of the portfolio, ranked #296.

Tema ETFs first reported a position in JANX in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.24M in Q1 2025. 14 funds tracked by Wall St. Rank hold JANX as of Q3 2026.

Tema ETFs held 55,053 shares of Janux Therapeutics worth $951K as of Q3 2026.
Tema ETFs bought 3,531 Janux Therapeutics shares in Q3 2026, an estimated $59.3K.
Janux Therapeutics made up 0.04% of Tema ETFs's portfolio in Q3 2026, its #296 holding.
Tema ETFs first reported a position in Janux Therapeutics in Q4 2024 and has held it in 8 quarters since.
Tema ETFs's Janux Therapeutics position peaked at $1.24M in Q1 2025.
14 funds tracked by Wall St. Rank held Janux Therapeutics as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.